Maravai LifeSciences Holdings, Inc. MRVI Return on equity

Return on equity at other companies

Thermo Fisher ScientificTMO

13.5%+0.1pp

DanaherDHR

7.6%+1.0pp

RepligenRGEN

2%+1.6pp

Bio-Rad LaboratoriesBIO

2.5%+1.3pp

Ginkgo BioworksDNA

-56.3%+23.1pp

Charles River LaboratoriesCRL

-7.7%—

FAQ

What is Maravai LifeSciences Holdings, Inc.'s return on equity?

Maravai LifeSciences Holdings, Inc. (MRVI) reported return on equity of -32.9% in Q2 2026.

How has Maravai LifeSciences Holdings, Inc.'s return on equity changed year-over-year?

Maravai LifeSciences Holdings, Inc.'s return on equity increased by 40.1% year-over-year, from -55% to -32.9%.

What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s return on equity?

Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s return on equity has grown at a -14.3% compound annual growth rate (CAGR), from 90.1% to -48.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.